A61K - Preparations for medical, dental, or toilet purposes

More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)

Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
11/2006
11/16/2006	US20060258646 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/16/2006	US20060258642 Confining solid tumors; administering a tyrosine kinase inhibitor as antitumor agents; 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline
11/16/2006	US20060258618 Anti-inflammatory substituted phenols and elastomeric compositions for oral delivery of drugs
11/16/2006	US20060258577 Antiviral agents for the treatment, control and prevention of infections by coronaviruses
11/16/2006	US20060258572 Somatostatin-dopamine chimeric analogs
11/16/2006	US20060258569 Compounds and methods for treating cancer
11/16/2006	US20060257977 Slowly digestible starch
11/16/2006	US20060257643 Hydrophobic composites and particulates and applications thereof
11/16/2006	US20060257558 Plasma polymerization of atomically modified surfaces
11/16/2006	US20060257414 Mycoplasma gallisepticum formulation
11/16/2006	US20060257412 Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells
11/16/2006	US20060257404 Modulators of the P2Y10 receptor useful in altering T lymphocyte function
11/16/2006	US20060257390 Catheter Composition and Uses Thereof
11/16/2006	US20060257384 Compositions comprising lactobacillus plantarum strains in combination with tannin and new lactobacillus plantarum strains
11/16/2006	US20060257333 Skin care product containing tall oil fatty acids and vegetable oils for dry and scaling skin and treatment of psoriasis, dermatitis, and eczemas
11/15/2006	EP1721605A1 Methods of treating capsules and dry, powdered pharmaceutical formulations
11/15/2006	EP1670315A4 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
11/15/2006	EP1513800B1 N-benzoylureidocinnamate derivatives, method for production and use thereof
11/15/2006	EP1345942B9 Pyrazinoquinoxaline derivatives as serotonin agonists and antagonists
11/15/2006	EP0969836B1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/15/2006	CN1863923A Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
11/15/2006	CN1863798A 2,4-dioxo-3-quinazolinylaryl sulfonylureas
11/15/2006	CN1863774A Compounds and compositions as protein kinase inhibitors
11/15/2006	CN1863556A Compositions and methods for treating coagulation related disorders
11/15/2006	CN1863546A Methods for treating cardiovascular disease using a soluble ctla4 molecule
11/15/2006	CN1863536A Sigma-1 receptor ligand with acetylcholinesterase
11/15/2006	CN1863525A Protective and therapeutic uses for tocotrienols
11/15/2006	CN1863516A Multilayer dosage form comprising a matrix that influences release of a modulatory substance
11/14/2006	US7135575 P38 inhibitors and methods of use thereof
11/14/2006	US7135571 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
11/14/2006	US7135553 Polymerizing hemoglobin with glutaraldehyde in solution, treating the polymerized hemoglobin to elaborate tetramer and removing tetramer from the polymerized hemoglobin solution
11/14/2006	US7135467 HIV integrase inhibitors
11/14/2006	CA2261787C Multi-layered osmotic device
11/09/2006	WO2005055955B1 DOSING METHODS FOR ß-D-2’,3’-DIDEOXY-2’,3’-DIDEHYDRO-5-FLUOROCYTIDINE ANTIVIRAL THERAPY
11/09/2006	WO2005055948A3 Epha2, epha4 and lmw-ptp and methods of treatment of hyperproliferative cell disorders
11/09/2006	WO2005048926A3 Methods for treating pain
11/09/2006	WO2004069153A3 Apparatus, system and method for generating bubbles on demand
11/09/2006	US20060252764 HIV inhibiting pyrimidines derivatives
11/09/2006	US20060252741 3-(2-amino-1-azacyclyl)-5-aryl-1,2,4-oxadiazoles as s1p receptor agonists
11/09/2006	US20060252722 Oligomeric compounds and compositions for use in modulation of pri-mirnas
11/09/2006	US20060252691 Topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration of a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance
11/09/2006	US20060252155 Methods for site-directed mutagenesis and targeted randomization
11/09/2006	US20060252052 Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same
11/09/2006	US20060252036 Alteration of rab38 function to modulate mammalian pigmentation
11/09/2006	US20060251735 Agents and methods for enhancing bone formation by oxysterols in combination with bone morphogenic proteins
11/09/2006	US20060251724 Method for preparing thermoformed compositions containing acrylic polymer binders, pharmaceutical dosage forms and methods of preparing the same
11/09/2006	US20060251657 Treatment kit which assists with antibiotic therapy for intracellular infectious diseases
11/09/2006	US20060251592 Isoflavone derivatives
11/09/2006	US20060248664 3-methyl-1,3,5-pentanetriol, 1,2,4-butanetriol, 1,5-pentanediol, 2-methyl-1,3-propanediol, 3-methyl-1,5-pentanediol, neopentyl glycol, isoprene glycol, or hexylene glycol; contains no glycerol and no cationic synthetic thickening polymer havng a fatty chain.
11/08/2006	EP1719512A2 Sarsasapogenin and smilagenin for treating cognitive dysfunctions
11/08/2006	EP1497322A4 Treatment of infections and other disorders
11/08/2006	EP1303514B9 Process for preparing azacycloalkanoylaminothiazoles
11/08/2006	CN1860118A Compounds and compositions as protein kinase inhibitors
11/08/2006	CN1860116A Bicyclic compounds and compostions as pdf inhibitors
11/08/2006	CN1860111A Compounds and compositions as protein kinase inhibitors
11/08/2006	CN1859914A Phenyl pyrrolidine ether tachykinin receptor antagonists
11/08/2006	CN1859908A 3,5-aryl, heteroaryl or cycloalkyl substituted-1,2,4-oxadiazoles as S1P receptor agonists
11/08/2006	CN1859904A Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
11/08/2006	CN1859899A Coated metal pyrithione particles for treatment of microorganisms
11/08/2006	CN1859846A Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders
11/07/2006	US7132560 Reacting N-methacryloyl-4-cyano-3-trifluoromethylaniline with mono-perphthalic acid to form 4-cyano-N-(2,3-epoxy-2-methylpropionyl)-3-trifluoromethylaniline
11/07/2006	US7132532 Compounds useful in the manufacture of an anti-inflammatory androstane derivative
11/07/2006	US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/07/2006	US7132432 Antiinflammatory agents; vision defects; autoimmune diseases; hepatitis; cardiovascular disordersl chronic fatigue syndromel chronic ostructive pulmonary disease; congestive heart failure
11/07/2006	US7132416 Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia
11/07/2006	US7132398 Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor
11/07/2006	US7132291 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
11/07/2006	US7132267 contacting the 4-halo-3-hydroxybutyric acid/ester/amide with a halohydrin dehalogenase and cyanide under conditions to form reaction mixture for converting the 4-halo-3-hydroxybutyric acid/ester/amide to a 4-cyano-3-hydroxybutyric acid/ester/amide
11/07/2006	CA2200578C N-substituted piperidinyl bicyclic benzoate derivatives
11/02/2006	WO2006114474A2 Saline solution comprising [13n] nh4+ and a device
11/02/2006	WO2005070080A3 Methods of using zonisamide as an adjunctive therapy for partial seizures
11/02/2006	WO2005046609A3 Process for producing hollow tubular fibers from legume hulls
11/02/2006	WO2005041899A3 Orally available sphingosine 1-phosphate receptor agonists and antagonists
11/02/2006	WO2005004793A9 Compositions and methods for treating coagulation related disorders
11/02/2006	US20060247432 Synthesis of 5-Azacytidine
11/02/2006	US20060247309 Compounds for the treatment of metabolic disorders
11/02/2006	US20060247247 Pyrazole-amine compounds useful as kinase inhibitors
11/02/2006	US20060247211 Cytotoxic indeno and isoindoloisoquinolones
11/02/2006	US20060247190 Compositions and methods for treating human papillomavirus mediated disease
11/02/2006	US20060247189 Forms of 5-Azacytidine
11/02/2006	US20060246525 Method of screening remedy for heart disease and medicinal composition for treating heart disease
11/02/2006	US20060246114 Multiple component food product useful for delivering glucosamine and/or nacetyl-d-glucosamine
11/02/2006	US20060246057 Treatment or prevention of damage due to radiation exposure
11/02/2006	US20060246050 Catheter Composition and Uses Thereof
11/02/2006	EP1715921A2 Tetrahydroindolone derivatives for treatment of neurological conditions
11/02/2006	EP1715876A1 New synbiotic use
11/02/2006	EP1715859A1 Method of treating and diagnosing sleep disordered breathing using zonisamide and means for carrying out the method
11/02/2006	EP1434624B1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors
11/02/2006	EP0973534B1 Plant extracts having appetite suppressant activity
11/01/2006	CN1856475A 异喹啉钾通道抑制剂 Isoquinoline potassium channel inhibitors
11/01/2006	CN1856474A Isoquinolinone potassium channel inhibitors
11/01/2006	CN1856307A Quinoline potassium channel inhibitors
11/01/2006	CN1856299A 口服药物释出系统 Oral drug release system
11/01/2006	CN1856295A Controlled release compositions
11/01/2006	CN1856258A Calcium dietary supplement
11/01/2006	CN1856253A Anti-virus hydrophilic polymeric material
11/01/2006	CN1854138A 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias
11/01/2006	CN1854118A Indane acetic acid compound
10/2006
10/31/2006	US7129717 Systems and methods for measuring tear film osmolarity
10/31/2006	US7129240 1,3-dihydro-2H-indol-2one derivatives, process for preparing them and pharmaceutical compositions containing them

1 ... 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 ... 295